Increased tau expression in the <i>APOE4</i> blood-brain barrier model is associated with reduced anti-tau therapeutic antibody delivery <i>in vitro</i>
Joanna M. Wasielewska(German Center for Neurodegenerative Diseases), Anthony R. White(QIMR Berghofer Medical Research Institute), Jürgen Götz(The University of Queensland), Alice Pébay(The Royal Melbourne Hospital), Rinie Bajracharya(The University of Queensland), Rebecca L. Johnston(QIMR Berghofer Medical Research Institute), Rebecca M. Nisbet(The University of Melbourne), Juliana C.S. Chaves(Queensland University of Technology), Lotta E. Oikari(Queensland University of Technology)
Cited by 3
Related Papers
Genome-wide analysis of long noncoding RNA stability
|Genome Research|2012|592
Metalloenzyme-like Activity of Alzheimer's Disease β-Amyloid
|Journal of Biological Chemistry|2002|575
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
|Nature Genetics|2013|544
Tau Filament Formation in Transgenic Mice Expressing P301L Tau
|Journal of Biological Chemistry|2001|515
Degradation of the Alzheimer Disease Amyloid β-Peptide by Metal-dependent Up-regulation of Metalloprotease Activity
|Journal of Biological Chemistry|2006|283